動脈瘤性くも膜下出血薬の世界市場2020-2026:オピオイド鎮痛薬、カルシウム拮抗薬、抗けいれん薬、便軟化剤、浸透圧剤、その他の薬剤

QYResearchが発行した調査報告書(QYR20AP00083)
◆英語タイトル:Global Aneurysmal Subarachnoid Hemorrhage Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00083
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、動脈瘤性くも膜下出血薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、動脈瘤性くも膜下出血薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(オピオイド鎮痛薬、カルシウム拮抗薬、抗けいれん薬、便軟化剤、浸透圧剤、その他の薬剤)、用途別市場規模(病院、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・動脈瘤性くも膜下出血薬の種類別市場2015-2026:オピオイド鎮痛薬、カルシウム拮抗薬、抗けいれん薬、便軟化剤、浸透圧剤、その他の薬剤
・動脈瘤性くも膜下出血薬の用途別市場2015-2026:病院、その他
・動脈瘤性くも膜下出血薬の北米市場分析
・動脈瘤性くも膜下出血薬のアジア市場分析
・動脈瘤性くも膜下出血薬の中南米市場分析
・動脈瘤性くも膜下出血薬の中東・アフリカ市場分析
・関連企業情報:Arbor Pharmaceuticals、Edge Therapeutics、Johnson & Johnson、Mylan N.V、Orexo AB、Pfizer、Purdue Pharma、Pharmaxis、Sun Pharmaceutical Industries、Teva Pharmaceutical
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke caused by bleeding in the space surrounding the brain.The global aneurysmal subarachnoid hemorrhage drugs market is segmented based on drug class and region. Based on drug class, the market is segmented into opioid analgesic, calcium channel blocker, anticonvulsant, stool softener, osmotic agent/diuretic, and other drugs.
In 2019, the global Aneurysmal Subarachnoid Hemorrhage Drugs market size was US$ 151.9 million and is forecast to US$ 175.3 million in 2026, growing at a CAGR of 2.0% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Aneurysmal Subarachnoid Hemorrhage Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Aneurysmal Subarachnoid Hemorrhage Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Aneurysmal Subarachnoid Hemorrhage Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Aneurysmal Subarachnoid Hemorrhage Drugs market. Readers of the report can become informed about current and future trends of the global Aneurysmal Subarachnoid Hemorrhage Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Aneurysmal Subarachnoid Hemorrhage Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Aneurysmal Subarachnoid Hemorrhage Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Aneurysmal Subarachnoid Hemorrhage Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Aneurysmal Subarachnoid Hemorrhage Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Aneurysmal Subarachnoid Hemorrhage Drugs market is segmented into
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic Agent
Other Drugs

Market Segment by Application, the Aneurysmal Subarachnoid Hemorrhage Drugs market is segmented into
Hospital
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Arbor Pharmaceuticals
Edge Therapeutics
Johnson & Johnson
Mylan N.V
Orexo AB
Pfizer
Purdue Pharma
Pharmaxis
Sun Pharmaceutical Industries
Teva Pharmaceutical

The study objectives are:
To analyze and research the global Aneurysmal Subarachnoid Hemorrhage Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Aneurysmal Subarachnoid Hemorrhage Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Opioid Analgesic
1.3.3 Calcium Channel Blocker
1.3.4 Anticonvulsant
1.3.5 Stool Softener
1.3.6 Osmotic Agent
1.3.7 Other Drugs
1.4 Market Segment by Application
1.4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2015-2026)
2.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (2015-2026)
2.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (2015-2026)
2.2 Aneurysmal Subarachnoid Hemorrhage Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions (2015-2020)
2.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions (2015-2020)
2.3 Global Top Aneurysmal Subarachnoid Hemorrhage Drugs Regions (Countries) Ranking by Market Size
2.4 Aneurysmal Subarachnoid Hemorrhage Drugs Industry Trends
2.4.1 Aneurysmal Subarachnoid Hemorrhage Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Aneurysmal Subarachnoid Hemorrhage Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Aneurysmal Subarachnoid Hemorrhage Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Aneurysmal Subarachnoid Hemorrhage Drugs Sales in 2019
3.2 Global Top Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs by Revenue
3.2.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs as of 2019)
3.4 Global Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Aneurysmal Subarachnoid Hemorrhage Drugs Market
3.7 Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Aneurysmal Subarachnoid Hemorrhage Drugs Price by Type (2015-2020)
4.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Aneurysmal Subarachnoid Hemorrhage Drugs Price Forecast by Type (2021-2026)

5 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Application
5.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application (2015-2020)
5.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Aneurysmal Subarachnoid Hemorrhage Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Company
6.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Type
6.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Application
6.4 North America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Countries
6.4.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries
6.4.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Company
7.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Type
7.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Application
7.4 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Countries
7.4.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries
7.4.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Company
8.2 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Type
8.3 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Application
8.4 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions
8.4.2 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Company
9.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Type
9.3 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Application
9.4 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Countries
9.4.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries
9.4.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Type
10.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Application
10.3 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries
10.3.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Arbor Pharmaceuticals
11.1.1 Arbor Pharmaceuticals Corporation Information
11.1.2 Arbor Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.1.5 Arbor Pharmaceuticals SWOT Analysis
11.1.6 Arbor Pharmaceuticals Recent Developments
11.2 Edge Therapeutics
11.2.1 Edge Therapeutics Corporation Information
11.2.2 Edge Therapeutics Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.2.5 Edge Therapeutics SWOT Analysis
11.2.6 Edge Therapeutics Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Johnson & Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.3.5 Johnson & Johnson SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Mylan N.V
11.4.1 Mylan N.V Corporation Information
11.4.2 Mylan N.V Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.4.5 Mylan N.V SWOT Analysis
11.4.6 Mylan N.V Recent Developments
11.5 Orexo AB
11.5.1 Orexo AB Corporation Information
11.5.2 Orexo AB Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.5.5 Orexo AB SWOT Analysis
11.5.6 Orexo AB Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.6.5 Pfizer SWOT Analysis
11.6.6 Pfizer Recent Developments
11.7 Purdue Pharma
11.7.1 Purdue Pharma Corporation Information
11.7.2 Purdue Pharma Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.7.5 Purdue Pharma SWOT Analysis
11.7.6 Purdue Pharma Recent Developments
11.8 Pharmaxis
11.8.1 Pharmaxis Corporation Information
11.8.2 Pharmaxis Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.8.5 Pharmaxis SWOT Analysis
11.8.6 Pharmaxis Recent Developments
11.9 Sun Pharmaceutical Industries
11.9.1 Sun Pharmaceutical Industries Corporation Information
11.9.2 Sun Pharmaceutical Industries Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.9.5 Sun Pharmaceutical Industries SWOT Analysis
11.9.6 Sun Pharmaceutical Industries Recent Developments
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Corporation Information
11.10.2 Teva Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Products and Services
11.10.5 Teva Pharmaceutical SWOT Analysis
11.10.6 Teva Pharmaceutical Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Aneurysmal Subarachnoid Hemorrhage Drugs Sales Channels
12.2.2 Aneurysmal Subarachnoid Hemorrhage Drugs Distributors
12.3 Aneurysmal Subarachnoid Hemorrhage Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast (2021-2026)
13.1.1 Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast (2021-2026)
13.2.2 North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast (2021-2026)
13.2.3 North America Aneurysmal Subarachnoid Hemorrhage Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast (2021-2026)
13.3.2 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Aneurysmal Subarachnoid Hemorrhage Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Aneurysmal Subarachnoid Hemorrhage Drugs Key Market Segments
Table 2. Ranking of Global Top Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Growth Rate by Type 2021-2026 (K MT) & (Million US$)
Table 4. Major Manufacturers of Opioid Analgesic
Table 5. Major Manufacturers of Calcium Channel Blocker
Table 6. Major Manufacturers of Anticonvulsant
Table 7. Major Manufacturers of Stool Softener
Table 8. Major Manufacturers of Osmotic Agent
Table 9. Major Manufacturers of Other Drugs
Table 10. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Application 2019-2025 (K MT)
Table 11. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size by Regions 2015-2020 (K MT) & (Million US$)
Table 12. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions 2015-2020 (K MT)
Table 13. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions 2015-2020
Table 14. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions 2015-2020 (Million US$)
Table 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Regions 2015-2020
Table 16. Top Aneurysmal Subarachnoid Hemorrhage Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 17. Market Top Trends
Table 18. Aneurysmal Subarachnoid Hemorrhage Drugs Key Drivers: Impact Analysis (2021-2026)
Table 19. Aneurysmal Subarachnoid Hemorrhage Drugs Key Challenges
Table 20. Main Points Interviewed from Key Aneurysmal Subarachnoid Hemorrhage Drugs Players: Views for Future
Table 21. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 22. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Manufacturers (2015-2020)
Table 23. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 24. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers (2015-2020)
Table 25. Global Aneurysmal Subarachnoid Hemorrhage Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysmal Subarachnoid Hemorrhage Drugs as of 2019)
Table 27. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Average Selling Price (ASP) (2015-2020) (USD/MT)
Table 28. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Plants/Factories Distribution
Table 29. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Area Served
Table 30. Date of Key Manufacturers Enter into Aneurysmal Subarachnoid Hemorrhage Drugs Market
Table 31. Key Manufacturers Aneurysmal Subarachnoid Hemorrhage Drugs Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Opioid Analgesic Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 34. Global Calcium Channel Blocker Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 35. Global Anticonvulsant Sales ana Revenue (2015-2020) (K MT) & (Million US$)
Table 36. Global Stool Softener Sales ana Revenue (2015-2020) (K MT) & (Million US$)
Table 37. Global Osmotic Agent Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 38. Global Other Drugs Sales and Revenue (2015-2020) (K MT) & (Million US$)
Table 39. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2015-2020)
Table 40. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2015-2020)
Table 41. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (K MT) by Type (2015-2020)
Table 43. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Type (2021-2026)
Table 44. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Type (2021-2026)
Table 45. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2021-2026)
Table 47. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (K MT) by Type (2021-2026)
Table 48. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT) by Application (2015-2020)
Table 49. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2015-2020)
Table 50. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price by Application 2015-2020 (USD/MT)
Table 52. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 53. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Application (2015-2020)
Table 54. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2021-2026)
Table 56. Global Aneurysmal Subarachnoid Hemorrhage Drugs Price (K MT) by Application (2021-2026)
Table 57. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Company (2015-2020) (K MT)
Table 58. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Company (2015-2020)
Table 59. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2015-2020) (K MT)
Table 60. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2015-2020)
Table 61. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 62. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
Table 63. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 64. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 65. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (Million US$)
Table 66. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 67. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Company (2015-2020) (K MT)
Table 68. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Company (2015-2020)
Table 69. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2015-2020) (K MT)
Table 70. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2015-2020)
Table 71. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 72. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
Table 73. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 74. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 75. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (Million US$)
Table 76. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Regions (2015-2020) (K MT)
Table 78. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions (2015-2020)
Table 79. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2015-2020) (K MT)
Table 80. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2015-2020)
Table 81. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 82. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
Table 83. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 84. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions (2015-2020)
Table 85. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Regions (2015-2020) (Million US$)
Table 86. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Regions (2015-2020)
Table 87. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Company (2015-2020) (K MT)
Table 88. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Company (2015-2020)
Table 89. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2015-2020) (K MT)
Table 90. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2015-2020)
Table 91. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 92. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
Table 93. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 94. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 95. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (Million US$)
Table 96. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Type (2015-2020) (K MT)
Table 98. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Type (2015-2020)
Table 99. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Application (2015-2020) (K MT)
Table 100. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application (2015-2020)
Table 101. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales by Countries (2015-2020) (K MT)
Table 102. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Countries (2015-2020)
Table 103. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue by Countries (2015-2020) (Million US$)
Table 104. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share by Countries (2015-2020)
Table 105. Arbor Pharmaceuticals Company Details
Table 106. Arbor Pharmaceuticals Description and Business Overview
Table 107. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 109. Arbor Pharmaceuticals Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 110. Arbor Pharmaceuticals Recent Development
Table 111. Edge Therapeutics Company Details
Table 112. Edge Therapeutics Description and Business Overview
Table 113. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 115. Edge Therapeutics Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 116. Edge Therapeutics Recent Development
Table 117. Johnson & Johnson Company Details
Table 118. Johnson & Johnson Description and Business Overview
Table 119. Johnson & Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Johnson & Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 121. Johnson & Johnson Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 122. Johnson & Johnson Recent Development
Table 123. Mylan N.V Company Details
Table 124. Mylan N.V Description and Business Overview
Table 125. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 127. Mylan N.V Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 128. Mylan N.V Recent Development
Table 129. Orexo AB Company Details
Table 130. Orexo AB Description and Business Overview
Table 131. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 133. Orexo AB Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 134. Orexo AB Recent Development
Table 135. Pfizer Company Details
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 139. Pfizer Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 140. Pfizer Recent Development
Table 141. Purdue Pharma Company Details
Table 142. Purdue Pharma Description and Business Overview
Table 143. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 145. Purdue Pharma Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 146. Purdue Pharma Recent Development
Table 147. Pharmaxis Company Details
Table 148. Pharmaxis Description and Business Overview
Table 149. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 150. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 151. Pharmaxis Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 152. Pharmaxis Recent Development
Table 153. Sun Pharmaceutical Industries Company Details
Table 154. Sun Pharmaceutical Industries Description and Business Overview
Table 155. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 156. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 157. Sun Pharmaceutical Industries Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 158. Sun Pharmaceutical Industries Recent Development
Table 159. Teva Pharmaceutical Company Details
Table 160. Teva Pharmaceutical Description and Business Overview
Table 161. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020)
Table 163. Teva Pharmaceutical Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share in Global Market
Table 164. Teva Pharmaceutical Recent Development
Table 165. Aneurysmal Subarachnoid Hemorrhage Drugs Distributors List
Table 166. Aneurysmal Subarachnoid Hemorrhage Drugs Customers List
Table 167. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast 2021-2026 (K MT) & (Million US$)
Table 168. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Type 2021-2026 (K MT)
Table 169. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Application 2021-2026 (K MT)
Table 170. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Regions 2021-2026 (K MT)
Table 171. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 172. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Countries 2021-2026 (K MT)
Table 173. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Countries 2021-2026
Table 174. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Countries 2021-2026 (K MT)
Table 175. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 176. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Regions 2021-2026 (K MT)
Table 177. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 178. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Countries 2021-2026 (K MT)
Table 179. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 180. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Forecast by Regions 2021-2026 (K MT)
Table 181. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Aneurysmal Subarachnoid Hemorrhage Drugs Product Picture
Figure 2. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Shar by Type 2015-2026
Figure 3. Opioid Analgesic Figures
Figure 4. Calcium Channel Blocker Figures
Figure 5. Anticonvulsant Figures
Figure 6. Stool Softener Figures
Figure 7. Osmotic Agent Figures
Figure 8. Other Drugs Figures
Figure 9. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Application in 2019 & 2026
Figure 10. Hospital Use Case
Figure 11. Others Use Case
Figure 12. Aneurysmal Subarachnoid Hemorrhage Drugs Report Years Considered
Figure 13. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size 2015-2026 (Million US$)
Figure 14. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales 2015-2020 (K MT)
Figure 15. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Size Market Share by Regions 2015-2020
Figure 16. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Market Share by Regions in 2019
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Aneurysmal Subarachnoid Hemorrhage Drugs Sales Share by Manufacturers in 2019
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Aneurysmal Subarachnoid Hemorrhage Drugs Sales in 2019
Figure 20. Aneurysmal Subarachnoid Hemorrhage Drugs Value Share by Manufacturers in 2019
Figure 21. Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Manufacturers In 2019
Figure 22. Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Type (2015-2020)
Figure 24. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 25. Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Share by Application (2015-2020)
Figure 27. Global Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 28. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. U.S. Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 30. Canada Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 31. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 32. Germany Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 33. France Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.K. Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. Italy Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. Russia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 38. China Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 39. Japan Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 40. South Korea Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. India Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 42. Australia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Taiwan Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Indonesia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Thailand Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. Malaysia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. Philippines Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. Vietnam Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Mexico Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Brazil Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Argentina Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 54. Turkey Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. Saudi Arabia Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. U.A.E Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Arbor Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Edge Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Mylan N.V Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Orexo AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Pharmaxis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Aneurysmal Subarachnoid Hemorrhage Drugs Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 71. North America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 73. Europe Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 75. Asia Pacific Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 77. Latin America Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 79. Middle East and Africa Aneurysmal Subarachnoid Hemorrhage Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed


【掲載企業】

Arbor Pharmaceuticals、Edge Therapeutics、Johnson & Johnson、Mylan N.V、Orexo AB、Pfizer、Purdue Pharma、Pharmaxis、Sun Pharmaceutical Industries、Teva Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 動脈瘤性くも膜下出血薬の世界市場2020-2026:オピオイド鎮痛薬、カルシウム拮抗薬、抗けいれん薬、便軟化剤、浸透圧剤、その他の薬剤(Global Aneurysmal Subarachnoid Hemorrhage Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。